mortality/aging
• mice die at approximately 1 year of age
|
cardiovascular system
• mice exhibit focal areas of fibrosis
• mice treated daily with SB216763 at 6 months of age do not show cardiac fibrosis
|
• mice exhibit frequent short runs of ventricular tachycardia
|
• mice exhibit frequent ventricular ectopy
• SB216763 treatment reduces ventricular ectopy
|
• hearts exhibit focal areas of inflammation
• mice treated daily with the GSK3B inhibitor SB216763 at 6 months of age do not show cardiac inflammation
|
immune system
• hearts exhibit focal areas of inflammation
• mice treated daily with the GSK3B inhibitor SB216763 at 6 months of age do not show cardiac inflammation
|
muscle
• hearts exhibit increased apoptotic cardiomyocytes
• mice treated daily with SB216763 at 6 months of age show elimination of cardiomyocyte apoptosis
|
cellular
• hearts exhibit increased apoptotic cardiomyocytes
• mice treated daily with SB216763 at 6 months of age show elimination of cardiomyocyte apoptosis
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
arrhythmogenic right ventricular dysplasia 12 | DOID:0110083 |
OMIM:611528 |
J:235770 |